TF and breast cancer: In agreement with the data generated with transfected-endothelial cells, siRNA-mediated knock-down of PPT1 and PPT2 in the breast cancer cell line MDA-MB-231, which constitutively expresses TF, also reduced fXa-generation (Figure 2F).